Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Business

Burrill, Partner Plan Minnesota Biotech Park

by Michael McCoy
March 23, 2009 | A version of this story appeared in Volume 87, Issue 12

Burrill & Co., the San Francisco-based life sciences investment firm, is teaming up with real estate developer Tower Investments to create Elk Run, a bioscience business park in Pine Island, Minn., near the Mayo Clinic. The partners say the 2,325-acre park will have a companion private equity/venture capital fund that supports development of new technologies emanating from Mayo, the University of Minnesota, and private entities. Elk Run is also expected to attract new biotech and biomedical businesses to Minnesota. Founded and led by G. Steven Burrill, Burrill & Co. claims to have assets worth nearly $1 billion under management. "We recognize that, at a time of economic dislocation around the world, investing in innovative life sciences companies and attracting these companies to the region will create jobs and ultimately improve patient care," Burrill says.

Article:

This article has been sent to the following recipient:

0 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.